Stephen Challacombe
About
In The Last Decade
Stephen Challacombe
273 papers receiving 11.0k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Periodontics 3.7k
- Epidemiology 3.2k
- Infectious Diseases 3.1k
- Physiology 2.0k
- Immunology 1.8k
Countries citing papers authored by Stephen Challacombe
This map shows the geographic impact of Stephen Challacombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Challacombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Challacombe more than expected).
Fields of papers citing papers by Stephen Challacombe
This network shows the impact of papers produced by Stephen Challacombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Challacombe. The network helps show where Stephen Challacombe may publish in the future.
Co-authorship network of co-authors of Stephen Challacombe
This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Challacombe. A scholar is included among the top collaborators of Stephen Challacombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Challacombe. Stephen Challacombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 17 | |
| 5 | 68 | |
| 6 | Experience with anti-TNF alpha therapy in the management of orofacial granulomatosis (OFG) | 2 |
| 7 | Epithelial cell discriminates between commensal and pathogenic Candida albicans via MAPK signaling independently of Dectin1, TLR2 or TLR4 | 1 |
| 8 | Evaluation of the efficacy of Colchicine with and without Betnesol mouthwash in management of RAS | 1 |
| 9 | Measurement of mucosal wetness in patients with xerostomia | 1 |
| 10 | 2 | |
| 11 | 0 | |
| 12 | Comparison of HIV-1 specific inhibitory activity in saliva and other human mucosal fluids. | 2 |
| 13 | 21 | |
| 14 | Treatment of mucosal lichen planus with mycophenolate mofetil: 18-month follow-up | 1 |
| 15 | Transmission of IgA and IgG monoclonal antibodies to saliva and other mucosal fluids after intranasal or parenteral delivery. | 1 |
| 16 | Inhibition of Candida albicans aspartyl proteinases by serum and saliva | 1 |
| 17 | A new ulcer scoring system for recurrent aphthous stomatitis | 2 |
| 18 | 3 | |
| 19 | ELISA and other solid phase immunoassys : theoretical and practical aspects | 40 |
| 20 | An immunogenetic basis for the tissue involvement in Behçet's syndrome. | 43 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.